<DOC>
	<DOCNO>NCT00819377</DOCNO>
	<brief_summary>Pulmonary hypertension important morbidity factor patient undergo cardiac surgery cardiopulmonary bypass ( ECC ) . Milrinone use inhalation , show evidence pulmonary vasodilator able possibly contribute reduction pressure pulmonary artery .</brief_summary>
	<brief_title>Milrinone Inhaled Cardiac Surgery</brief_title>
	<detailed_description>This control , randomize , double-blind study aim confirm efficiency well security Milrinone , use inhalation , diminish degree pulmonary hypertension cardiopulmonary bypass ( ECC ) circulation . In addition , pharmacokinetic echo graphic repercussion administer medication analyse . At present time , data pharmacokinetics medication 's administered inhalation . For reason , would like study serous rate medication minute follow administration inhalation .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Milrinone</mesh_term>
	<criteria>Adult patient schedule elective valvular complex ( 2 valve valve revascularization ) cardiac surgery CPB preoperative PHT define mean pulmonary artery pressure ( MPAP ) 30 mmHg systolic pulmonary artery pressure ( SPAP ) 40 mmHg ( use preoperative rightsided catheterization estimate echocardiography ) . Cardiac surgery require CPB , contraindication TEE ( esophageal pathology unstable cervical spine ) emergency surgery . Patients recruit day surgery randomize use computerized card pharmacy department</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Valvular surgery</keyword>
	<keyword>pulmonary artery pressure</keyword>
</DOC>